The field of cardio-oncology has expanded over the past 2 decades to address the ever-increasing issues related to cardiovascular disease in patients with cancer and survivors. There is increasing ...

It has two candidates in phase 3 – lurbinectedin for small-cell lung cancer and JZP351 (liposomal daunorubicin and cytarabine) for acute myeloid leukaemia. The deal is also a first partnership ...

[Influence of perfluorodecalin on growth of actinomycetes and intensification of Streptomycin and daunorubicin production by the genus Streptomyces kind bacteria in submerged culture].

Marlise R. Luskin, MD, MSCE, discussed treatment options for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and challenging disease.

The ODAC considered whether the new low dose in combination with daunorubicin and cytarabine had an acceptable safety profile, and to discuss whether event-free survival is an acceptable endpoint ...

After the first screening, the following compounds were purchased as candidate drugs: Bortezomib, Carfilzomib, Idarubicin, Doxorubicin, Epirubicin, Mitoxantrone, Daunorubicin, Camptothecin, ...

Doctors refer to hair loss that occurs as a side effect of medication as drug-induced alopecia. Hair loss can be a side effect of many different medications, such as those for chemotherapy ...

daunorubicin and cytarabine; ISTH, International Society on Thrombosis and Haemostasis; PR, prothrombin ratio. Due to 1) primary refractory disease and 2) the adverse prognosis associated with ...

Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. AML can affect people of any age, but it is most common in adults. AML occurs when bone marrow produces abnormal blood cells ...